Colon Registry: Influence of comorbidity on the choice of chemotherapeutic treatment. A joint project of the AIO and the AKS. 30. Mai 2008 Freier, W., Arnold, D., Otremba, B., Marschner, N., 2008. Onkologie 31 (suppl 4)(P301), 109. doi:10.1159/000161574 Abstract Download A prospective planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but not predictive for differential response to exemestane versus tamoxifen. Bartlett, J., Brookes, C., Billingham, L., Campell, F., Gnant, M., Hasenburg, A., Hille, E., Kay, C., Kieback, D., Markopoulos, C., Meershok-Klein Kranenberg, E., Mallon, E.,… Weiterlesen Bone Effects of Exemestane vs. Tamoxifen within the German TEAM trial: Results of a Prospective Randomized Bone Sub-Study. Hadji, P., Ziller, M., Kieback, D., Dornoff, W., Tessen, H., Kuck, J., Hasenburg, A., 2008. Cancer Res 69(2 Supplement), 1143. doi:10.1158/0008-5472.SABCS-1143… Weiterlesen